Viral Infection Impact on Chronic Respiratory Diseases

Viral infections such as influenza, respiratory syncytial virus and rhinovirus represent major precipitants of exacerbations in chronic respiratory diseases including asthma and chronic obstructive pulmonary disease. In these conditions, viral replication and host immune responses combine to provoke airway inflammation, hyperresponsiveness and tissue injury. Underlying disease alters antiviral defences, leading to prolonged viral persistence and heightened cytokine release, which in turn exacerbate airway obstruction, mucus hypersecretion and remodelling. Importantly, interplay between the viral insult and the airway microbiome can influence secondary bacterial infection, further complicating clinical course. Understanding the mechanisms by which viruses trigger and amplify chronic airway inflammation has guided the development of targeted antivirals, immunomodulatory strategies and preventive vaccination to reduce hospitalisation rates and improve long-term outcomes.

Research from Nature Portfolio

Recent murine investigations have demonstrated that allergic airway inflammation modifies the lung microbiome and attenuates the synergistic lethality of influenza A virus and Streptococcus pneumoniae co-infection. Allergic mice maintained alveolar macrophage populations and displayed reduced bacterial burden and lung damage, emphasising the role of pre-existing airway immunity in shaping co-infection outcomes. Earlier foundational work has characterised cytokine dynamics in asthmatic models following pandemic influenza A(H1N1) infection, revealing peaks in interleukin-6, tumour necrosis factor-α and interferon-γ that coincide with elevated viral titres and acute tissue injury. These studies elucidate how chronic inflammatory states alter antiviral responses and inform timing of therapeutic intervention.

Viral Infection Impact on Chronic Respiratory Diseases publication trend

The graph below shows the total number of articles in viral infection impact on chronic respiratory diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Alveolar macrophage: Resident immune cell in the lung responsible for pathogen clearance and immune regulation.

Cytokine storm: Excessive, dysregulated release of proinflammatory mediators causing tissue damage.

Co-infection: Concurrent infection by two or more pathogens influencing disease severity and outcome.

Hyperresponsiveness: Exaggerated bronchoconstrictive response of the airways to stimuli.

Transforming growth factor-β (TGF-β): Immunoregulatory cytokine that modulates inflammation and tissue repair.

References

1. Allergic inflammation alters the lung microbiome and hinders synergistic co-infection with H1N1 influenza virus and Streptococcus pneumoniae in C57BL/6 mice. Scientific Reports (2019).
2. Pulmonary inflammation and cytokine dynamics of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during A(H1N1)pdm09 influenza infection. Scientific Reports (2017).
3. Prevention of Influenza Virus-Induced Immunopathology by TGF-β Produced during Allergic Asthma. PLOS Pathogens (2015).
4. Resolved Influenza A Virus Infection Has Extended Effects on Lung Homeostasis and Attenuates Allergic Airway Inflammation in a Mouse Model. Microorganisms (2020).